Protocols developed for assay kits from Beacon Analytical Systems and
Romer Labs for use on SpectraMax(R) microplate readers with SoftMax(R)
Pro analytical software
SUNNYVALE, CA, Feb. 19 /CNW/ - MDS Analytical Technologies, a leader in
innovative solutions for drug discovery and life sciences research, today
announced that two new assay kits - the Melamine Plate Kit from Beacon
Analytical Systems, which focuses on the development and manufacture of
immunodiagnostic kits for environmental and food/feed testing markets, and the
AgraQuant Melamine ELISA Test Kits from Romer Labs, a leader in diagnostic
solutions for mycotoxins and genetically modified organisms - have been
validated for use on MDS Analytical Technologies' SpectraMax(R) absorbance
microplate readers with SoftMax(R) Pro 5 GxP analytical software, an
industry-standard analysis software for FDA 21 CFR Part 11 compliance.
This high-throughput solution from MDS Analytical Technologies offers a
cost-effective method for the detection of melamine, an organic industrial
polymer that has recently been found in various foods and may cause serious
illness or death. These enzyme-linked immunosorbent assay (ELISA) solutions
offer food-safety technicians more options in their continued effort to detect
the presence of melamine.
"Melamine contamination continues to be a major concern and emphasis on
finding effective detection methods is growing," said Andy Boorn, President of
MDS Analytical Technologies. "In the past three months, MDS Analytical
Technologies has now validated three such detection kits to run on our
hardware and software. We're very pleased to be the emerging leader in
high-throughput, cost-effective melamine detection solutions."
Mass-spectrometry systems made by MDS Analytical Technologies are also
used throughout the world to scan, identify and measure food contaminants,
such as melamine. Mass-spectrometry systems, including the recently announced
AB SCIEX QTRAP(R) 5500 and AB SCIEX Triple Quad(TM) 5500, deliver high
sensitivity, selectivity, high speed and reliability of results in laboratory
analysis, enabling rapid detection and ultimately stronger compliance with,
and enforcement of, food-safety regulations.
SpectraMax(R) microplate readers can be integrated with the MDS
Analytical Technologies' StakMax(R) microplate handling system. Technicians
may also configure the StakMax(R) system with MDS Analytical Technologies'
AquaMax(R) 4000 microplate washer. These combinations can be used to maximize
throughput while minimizing manual plate handling.
To download application notes on this method, please visit
www.moleculardevices.com/melamine. Alternatively, customers can call our
Customer Service department at (408) 747-1700 to speak to a sales
About SpectraMax(R) Absorbance Microplate Readers
MDS Analytical Technologies, which acquired Molecular Devices Corporation
in 2007, is a leading supplier of microplate reader systems to academic,
pharmaceutical, and biotechnology research groups worldwide. The Company
offers several multi-mode detection systems including SpectraMax(R) M5e and
SpectraMax(R) M2e microplate readers, as well as SpectraMax(R) 340 PC,
VersaMax(TM), VMax(R), and EMax(R) single-mode microplate readers. The
Company's SpectraMax(R) patented technologies, such as PathCheck(R)
well-volume detection, dual-monochromators, and SmartOptics design, enable
researchers more flexibility, sensitivity, and ease-of-use for the broadest
range of assays. The PathCheck(R) sensor is the only patented technology
available that measures the depth (optical pathlength) of a sample in a
microplate. When combined with SoftMax(R) Pro software, it automatically
normalizes the well absorbance to a cuvette equivalent pathlength of one
centimeter. The patented dual-monochromator design uses two scanning
monochromators to determine optimal excitation and emission settings,
eliminating the need for expensive filters. Find out more at
About SoftMax(R) Pro 5 GxP Analytical Software
SoftMax(R) Pro 5 GxP analytical software, which is FDA 21 CFR Part
11-compliant, raises the bar for microplate data acquisition and analysis.
This software solution, which runs on all microplate readers offered by MDS
Analytical Technologies, offers significant enhancements over previous
releases, including five parameter (5PL) logistic curve fitting; parallel line
analysis (PLA) with observation weighting; more than 120 ready-to-run assay
protocols for instant results generation; native support for Mac OS X; XML
export and multiple-destination AutoSave with new options; enhanced Windows
Interprocess Messaging for better robotics/LIMS/SDMS integration; more
detailed printed headers and footers; and full backwards-compatibility. Find
out more at http://www.moleculardevices.com/pages/software/softmax.html.
About MDS Analytical Technologies
MDS Analytical Technologies, a business unit of MDS Inc., is focused on
the research, design, manufacture and marketing of state-of-the-art tools for
mass-spectrometry, drug discovery and bioresearch. MDS Analytical
Technologies' products are designed to help accelerate the complex process of
discovering and developing new drug compounds, and are sold to research
scientists around the world. The mass-spectrometer product lines are also sold
globally through joint ventures with two of the world's leading analytical
instrumentation and life-sciences companies, Life Technologies Corporation and
PerkinElmer, Inc. Find out more at www.mdssciex.com or
About MDS Inc.
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life-sciences company that
provides market-leading products and services that our customers need for the
development of drugs and diagnosis and treatment of disease. We are a leading
global provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments. MDS, Inc.
has more than 5,000 highly skilled people in 29 countries. Find out more at
www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
For further information:
For further information: MEDIA: Tom Driscoll, (408) 747-3681,
email@example.com; INVESTORS: Kim Lee, (416) 213-4721,